Kurt Anker Nielsen - Introduction
Mads Øvlisen - Novo Nordisk Strategy
Kurt Anker Nielsen - Enzyme Business
Lars Rebien Sørensen - Health Care
Mads Krogsgaard Thomsen - Diabetes Care R&D
Kurt Anker Nielsen - Corporate Finance
Download Zip file containing MS Powerpoint version of Investor Presentations 1999 (1.64 MB)
Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 32,500 employees in 74 countries, and markets its products in 179 countries.
 | Novo Nordisk in the USA |
 | Novo Nordisk in Denmark |
Or choose:
